Prostate Cancer - Results from #27400

Editor's Commentary - Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment July 29, 2011

Treatment of metastatic bone disease and treatment-induced osteoporosis in prostate cancer : Evolution of osteoprotective strategies - Abstract July 28, 2011

The association of diagnosis in the private or NHS sector on prostate cancer stage and treatment - Abstract July 28, 2011

Emerging treatment options for patients with castration-resistant prostate cancer - Abstract July 28, 2011

Biological significance of perineural invasion (PNI) in prostate cancer - Abstract July 28, 2011

ASTRO publishes white paper on IMRT safety July 28, 2011

Editor's Commentary - Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen July 28, 2011

Understanding preventive behaviors among mid-Western African-American men: A pilot qualitative study of prostate screening - Abstract July 27, 2011

Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer - Abstract July 27, 2011

Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: Competing-risks analysis of a large North American population-based cohort - Abstract July 27, 2011

Quality of life, behavioral problems, and marital adjustment in the first year after radical prostatectomy - Abstract July 27, 2011

Editor's Commentary - Abiraterone and increased survival in metastatic prostate cancer July 27, 2011

The future of uro-oncology : What needs to be done to secure its place in the field of urology? - Abstract July 26, 2011

Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: Prospective comparison of diagnostic performance determined by masked reading - Abstract July 26, 2011

Natural orifice (NOTES) transurethral sutureless radical prostatectomy with thulium laser support: First patient report - Abstract July 26, 2011

Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA)-positive tumors using the quenched humanized J591 antibody-ICG conjugate - Abstract July 26, 2011

Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the Pten conditional knockout mouse proteome - Abstract July 26, 2011

Immunotherapy in prostate cancer: Emerging strategies against a formidable foe - Abstract July 26, 2011

New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: A comparative study - Abstract July 26, 2011

UT Southwestern scientists discover new pathway to potential therapies for advanced prostate cancer July 26, 2011

Page 1371 of 1436